Tomoe Mizutani
- Hematology top 5%
- Epidemiology
- Internal Medicine top 5%
- Critical Care and Intensive Care Medicine top 5%
- Molecular Biology
- Co-authors
- Hidesaku AsakuraEriko MorishitaYasuo OntachiShinji NakaoMinori KatoKeiji AoshimaKen‐ichi MiyamotoMasahide Yamazaki
- Topics
- Blood Coagulation and Thrombosis Mechanisms (14 papers)Blood properties and coagulation (8 papers)Platelet Disorders and Treatments (5 papers)
- Partner nations
- JapanUnited Kingdom
In The Last Decade
Tomoe Mizutani
20 papers receiving 320 citations
Peers
Comparison fields: 5 of 62
- Hematology 163
- Epidemiology 100
- Internal Medicine 91
- Critical Care and Intensive Care Medicine 70
- Molecular Biology 42
Countries citing papers authored by Tomoe Mizutani
This map shows the geographic impact of Tomoe Mizutani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoe Mizutani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoe Mizutani more than expected).
Fields of papers citing papers by Tomoe Mizutani
This network shows the impact of papers produced by Tomoe Mizutani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoe Mizutani. The network helps show where Tomoe Mizutani may publish in the future.
Co-authorship network of co-authors of Tomoe Mizutani
This figure shows the co-authorship network connecting the top 25 collaborators of Tomoe Mizutani. A scholar is included among the top collaborators of Tomoe Mizutani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoe Mizutani. Tomoe Mizutani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 5 | |
| 3 | 4 | |
| 4 | 53 | |
| 5 | 4 | |
| 6 | 1 | |
| 7 | 34 | |
| 8 | 6 | |
| 9 | A case of cardiac B cell lymphoma complicated by hemophagocytic syndrome. | 1 |
| 10 | 32 | |
| 11 | 49 | |
| 12 | 25 | |
| 13 | 5 | |
| 14 | 12 | |
| 15 | 63 | |
| 16 | 3 | |
| 17 | 14 | |
| 18 | 6 | |
| 19 | 13 | |
| 20 | The effect of chlorpromazine on paraquat poisoning in rats. | 3 |
About Tomoe Mizutani
Tomoe Mizutani is a scholar working on Hematology, Critical Care and Intensive Care Medicine and Internal Medicine, having authored 20 papers that have together received 346 indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (14 papers), Blood properties and coagulation (8 papers) and Platelet Disorders and Treatments (5 papers). The work is most often cited by research in Internal Medicine (91 citations), Hematology (163 citations) and Critical Care and Intensive Care Medicine (70 citations). Tomoe Mizutani has collaborated with scholars based in Japan and United Kingdom. Frequent co-authors include Hidesaku Asakura, Eriko Morishita, Yasuo Ontachi, Shinji Nakao, Minori Kato, Keiji Aoshima, Ken‐ichi Miyamoto, Masahide Yamazaki, Masanori Saito and Yukio Suga. Their work appears in journals such as Critical Care Medicine, Intensive Care Medicine and Thrombosis and Haemostasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.